US Patent 11174233 Anti-cancer compounds having oxazolone derivation
Patent 11174233 was granted and assigned to King Abdulaziz University on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+370 characters)
Article
Patent abstract
Cytotoxic compounds containing a phenyl core, amide link(s), an imidazolinone or a propenamide moiety. Also described are pharmaceutical compositions incorporating the cytotoxic compounds and methods for treating cancer. These compounds are cytotoxic against breast, prostate, and leukemia cancer cell lines via dual inhibition of Src kinases and tubulin.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Abdelsattar M. Omar0
Ahmed Esmat0
Ashraf B. Abdel-Naim0
Azizah M. Malebari0
Farid Ahmed0
Moustafa E. El-Araby0
Thikryat Neamatallah0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Nov, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11174233 Anti-cancer compounds having oxazolone derivation
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11174233
Date of patent
November 16, 2021
Patent application number
17377530
Date Filed
July 16, 2021
Patent primary examiner
Find more entities like US Patent 11174233 Anti-cancer compounds having oxazolone derivation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.